1. Ablordeppey SY, Borne RF (1993) Detection of a neurotoxic quaternary pyridinium metabolites in the liver of haloperidol-treated rats. Pharmacol Biochem Behav 46:739–744
2. Ashby CR Jr, Hitzemann R, Rubinstein JE, Wang RY (1989) One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat. Brain Res 493:194–197
3. Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Gilman GA, Goodman LS, Rall TW, Murad F (eds) Goodman and Gilman's pharmacological basis of therapeutics, 7th edn. Macmillan, New York, pp 385–445
4. Bloomquist J, King E, Wright A, Mytilineou C, Kimura K, Catagnoli K, Castagoli N Jr (1994) 1-Methyl-4-phenylpyridinium-like neurotoxicity of pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies. J Pharmacol Exp Ther 270:822–830
5. DiPasquale B, Marini AM, Youle RJ (1991) Apoptosis and DNA degradation induced byN-methyl-4-phenylpyridinium in neurons. Biochem Biophy Res Commun 181:1442–1448